NRIX: the balance sheet

MyFinsight

Nurix Therapeutics, Inc. (NRIX)

Balance Sheets	2026-02-28	2025-11-30	2025-08-31
Cash and cash equivalents	71,195	246,960	78,438
Marketable securities	469,537	345,981	350,391
Prepaid expenses and other current assets	13,662	13,878	11,774
Total current assets	554,394	606,819	440,603
Operating lease right-of-use assets	51,657	50,517	53,028
Property and equipment, net	21,697	22,490	20,498
Restricted cash	968	968	968
Other assets	7,414	7,341	7,375
Total assets	636,130	688,135	522,472

Accounts payable	10,293	11,215	8,609
Accrued expenses and other current liabilities	59,950	54,852	43,957
Operating lease liabilities, current	3,202	2,824	3,791
Deferred revenue, current	18,754	17,580	25,993
Total current liabilities	92,199	86,471	82,350
Operating lease liabilities, net of current portion	55,453	52,906	52,695
Deferred revenue, net of current portion	7,585	10,011	15,175
Total liabilities	155,237	149,388	150,220
Common stock, 0.001 par value 500,000,000 shares authorized as of february28, 2026 and november30, 2025 103,399,813 and 101,807,484 shares issued and outstanding as of february28, 2026 and november30, 2025, respectively	103	102	77
Additional paid-in capital	1,571,134	1,541,766	1,297,061
Accumulated other comprehensive income	56	105	119
Accumulated deficit	-1,090,400	-1,003,226	-925,005
Total stockholders equity	480,893	538,747	372,252
Total liabilities and stockholders equity	636,130	688,135	522,472

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.